Congressional Investigation into Alzheimer’s Drug Aduhelm Faults the F.D.A. and Biogen - HostGuest

HostGuest

New Blog. End Your Search Here.

Home Top Ad

Post Top Ad

Friday, December 30, 2022

Congressional Investigation into Alzheimer’s Drug Aduhelm Faults the F.D.A. and Biogen

The report said the F.D.A.’s approval process for Aduhelm was “rife with irregularities” and criticized Biogen for setting an “unjustifiably high price.”

from NYT > U.S. News https://ift.tt/AQh5wpl

No comments:

Post a Comment

Post Top Ad